We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
Cap. Flow
-$1.58B
Cap. Flow %
-0.53%
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1B
2
AAPL icon
Apple
AAPL
+$797M
3
MRK icon
Merck
MRK
+$316M
4
AMZN icon
Amazon
AMZN
+$308M
5
MDT icon
Medtronic
MDT
+$298M

Sector Composition

Rank Sector Weight
1 Technology 24.73%
2 Healthcare 13.29%
3 Consumer Discretionary 13.23%
4 Financials 12.2%
5 Communication Services 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STTK icon
2301
Shattuck Labs
STTK
$694M
$2.89M ﹤0.01%
+55,204
New +$1.77M
KRYS icon
2302
Krystal Biotech
KRYS
$9.66B
$2.89M ﹤0.01%
48,191
+1,217
+3% +$60.8K
SNP
2303
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
$2.89M ﹤0.01%
+64,705
New +$2.79M
IVR icon
2304
Invesco Mortgage Capital
IVR
$805M
$2.88M ﹤0.01%
85,249
+4,400
+5% +$136K
WTRE
2305
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
$2.88M ﹤0.01%
83,257
-5,066
-6% -$173K
ASAP
2306
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$2.86M ﹤0.01%
51,497
+11,642
+29% +$749K
AOUT icon
2307
American Outdoor Brands
AOUT
$157M
$2.86M ﹤0.01%
168,051
+52,520
+45% +$791K
MSGN
2308
DELISTED
MSG Networks Inc.
MSGN
$2.85M ﹤0.01%
193,296
-14,257
-7% -$159K
AQST icon
2309
Aquestive Therapeutics
AQST
$494M
$2.84M ﹤0.01%
531,086
+407,332
+329% +$2.44M
OBK icon
2310
Origin Bancorp
OBK
$1.66B
$2.83M ﹤0.01%
102,019
-1,924
-2% -$49K
AMRS
2311
DELISTED
Amyris Inc.
AMRS
$2.83M ﹤0.01%
458,680
+3,616
+0.8% +$11.6K
SINA
2312
DELISTED
Sina Corp
SINA
$2.81M ﹤0.01%
66,423
-6,332
-9% -$272K
MRVI icon
2313
Maravai LifeSciences
MRVI
$919M
$2.81M ﹤0.01%
+100,000
New +$2.78M
ALX
2314
Alexander's
ALX
$1.41B
$2.8M ﹤0.01%
8,534
-1,814
-18% -$480K
FBMS
2315
DELISTED
The First Bancshares, Inc.
FBMS
$2.8M ﹤0.01%
90,738
-4,204
-4% -$112K
BV icon
2316
BrightView Holdings
BV
$1.07B
$2.79M ﹤0.01%
184,546
+1,867
+1% +$25.6K
TBRG
2317
DELISTED
TruBridge
TBRG
$2.79M ﹤0.01%
103,984
+1,167
+1% +$32.9K
TCX icon
2318
Tucows
TCX
$175M
$2.79M ﹤0.01%
37,727
+489
+1% +$36.4K
BRY
2319
DELISTED
Berry Corp
BRY
$2.78M ﹤0.01%
756,693
-18,593
-2% -$64.3K
EFC
2320
Ellington Financial
EFC
$1.71B
$2.76M ﹤0.01%
186,033
-29,340
-14% -$408K
NFBK
2321
DELISTED
Northfield Bancorp
NFBK
$2.76M ﹤0.01%
223,720
-45,493
-17% -$504K
CENT icon
2322
Central Garden & Pet Co
CENT
$2.8B
$2.76M ﹤0.01%
89,240
+4,306
+5% +$138K
ORBC
2323
DELISTED
ORBCOMM, Inc.
ORBC
$2.75M ﹤0.01%
371,286
-43,212
-10% -$233K
WSBF icon
2324
Waterstone Financial
WSBF
$375M
$2.75M ﹤0.01%
146,081
-7,063
-5% -$123K
CPS icon
2325
Cooper-Standard Automotive
CPS
$558M
$2.75M ﹤0.01%
79,208
-9,805
-11% -$273K

Similar funds

Nuveen's Q4 2020 Portfolio in Review

As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
  • Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
  • Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
  • Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
  • Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
  • Nuveen opened 145 new positions and closed 125 in Q4 2020.
  • Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.

Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.